---
figid: PMC9097798__gr1
figtitle: Development of novel agents for the treatment of early estrogen receptor
  positive breast cancer
organisms:
- NA
pmcid: PMC9097798
filename: gr1.jpg
figlink: /pmc/articles/PMC9097798/figure/fig1/
number: F1
caption: Estrogen-dependent signalling and targets of small-molecular inhibitors.
  Summary of normal estrogen-dependent signalling pathways and the method of pathway
  disruption with small molecule inhibitors. E2, estrogen. And., androgens. EGF(R),
  epithelial growth factor (receptor). IGF(R), insulin-like growth factor (receptor).
  ERα, estrogen receptor alpha. ERE, estrogen response elements. P., phosphorylation.
  MAPK, mitogen-activated protein kinase. AKT, protein kinase B. Tam., tamoxifen.
  PI3K, phosphoinositide 3-kinase. mTOR, mammalian target of rapamycin. PI3Kα, phosphoinositide
  3-kinase alpha. SERD, selective estrogen receptor degraders. Created with BioRender.com.
papertitle: Development of novel agents for the treatment of early estrogen receptor
  positive breast cancer.
reftext: Mitchell J. Elliott, et al. Breast. 2022 Mar;62(Suppl 1):S34-S42.
year: '2022'
doi: 10.1016/j.breast.2021.11.007
journal_title: 'The Breast : Official Journal of the European Society of Mastology'
journal_nlm_ta: Breast
publisher_name: Elsevier
keywords: Breast cancer | Adjuvant therapy | Endocrine therapy | Targeted agents |
  Estrogen receptor | mTOR | PI3K | SERD | AKT | Early breast cancer | PARP inhibitor
automl_pathway: 0.9448793
figid_alias: PMC9097798__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC9097798__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9097798__gr1.html
  '@type': Dataset
  description: Estrogen-dependent signalling and targets of small-molecular inhibitors.
    Summary of normal estrogen-dependent signalling pathways and the method of pathway
    disruption with small molecule inhibitors. E2, estrogen. And., androgens. EGF(R),
    epithelial growth factor (receptor). IGF(R), insulin-like growth factor (receptor).
    ERα, estrogen receptor alpha. ERE, estrogen response elements. P., phosphorylation.
    MAPK, mitogen-activated protein kinase. AKT, protein kinase B. Tam., tamoxifen.
    PI3K, phosphoinositide 3-kinase. mTOR, mammalian target of rapamycin. PI3Kα, phosphoinositide
    3-kinase alpha. SERD, selective estrogen receptor degraders. Created with BioRender.com.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ESR1
  - ERAL1
  - TAM
  - STIM1
  - EGF
  - EGFR
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - IGF1
  - IGF1R
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - era
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - PolG1
  - pyd
  - Egfr
  - MKP-4
  - p38b
  - rl
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Mtor
  - Tor
---
